CEN1 HC-Br

General Information


DRACP ID  DRACP02885

Peptide Name   CEN1 HC-Br

Sequence  GXFKKTFHKVSHAVKSGIHAGQRGCSALGF

Sequence Length  30

UniProt ID  D8WN02 

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Active ACP



Activity Information


Cell Line Disease Cancer Classified Activity Assay Testing Time Literature
THP-1 Childhood acute monocytic leukemia; Acute monoblastic/monocytic leukemia Leukemia 50% Killing=100 mg/L MTT assay 6 h 1

Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antibacterial; Anti-inflammatory



Structure Information


PDB ID  Not available

Predicted Structure  Not available

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  X=Br-Trp

Chiral  L



Physicochemical Information


Formula  C137H213N43O34S

Absent amino acids  DEMNPWY

Common amino acids  G

Mass  366598

Pl  11.25

Basic residues  8

Acidic residues  0

Hydrophobic residues  10

Net charge  8

Boman Index  -3114

Hydrophobicity  -17.67

Aliphatic Index  55.33

Half Life 
  /

Extinction Coefficient cystines  0

Absorbance 280nm  0

Polar residues  10

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 23237525

Title  Anti-infectious and anti-inflammatory effects of peptide fragments sequentially derived from the antimicrobial peptide centrocin 1 isolated from the green sea urchin, Strongylocentrotus droebachiensis

Doi 10.1186/2191-0855-2-67

Year  2012

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DBAASP ID  DBAASPS_17825

DRACP is developed by Dr.Zheng's team.